Gemphire Therapeutics Inc. Human Resources Contracts & Agreements

37 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to the NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of June 7, 2024
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Amended and Restated Non-Employee Director Compensation Policy, dated May 7, 2024
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2024
Employment Agreement entered into on March 1, 2024 by and between NeuroBo Pharmaceuticals, Inc. and Marshall H. Woodworth
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2024
Employment Agreement entered into on August 11, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Hyung Heon Kim
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2023
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2023
Separation and Release Agreement entered into on January 16, 2023 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2023
NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan Forms of Option Grant Agreements
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan, effective as of December 22, 2022
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2022
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Gemphire Therapeutics Inc.
Biotechnology
2022
Employment Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Gil Price
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Separation Agreement entered into on November 3, 2021 by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2021
Employment Agreement, dated as of December 31, 2020, by and between the Registrant and Akash Bakshi
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Stock Unit Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Form of Non-Qualified Stock Option Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Form of Restricted Stock Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Form of Incentive Stock Option Agreement for 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2020
Employment Agreement, dated February 11, 2020, by and between NeuroBo Pharmaceuticals, Inc. and Richard Kang
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
MD
2020
Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated May 1, 2018 and extension of such agreement,...
Consulting Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
2019 Equity Incentive Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Seth Reno dated September 30, 2019
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Charles L. Bisgaier dated September 30, 2019
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Second Amendment to Employment Agreement between Gemphire Therapeutics Inc. and Dr. Steven Gullans dated September 30, 2019
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Form of Notice of Grant of Restricted Stock Bonus for NeuroBo Pharmaceuticals, Inc. to the 2018 Stock Plan
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Consulting Agreement by and between vZenium LLC, owned and managed entirely by Mark Versavel, and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement Consulting...
Consulting Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
Consulting Agreement by and between Healthcare Capital LLC, owned and managed entirely by John L. Brooks III and NeuroBo Pharmaceuticals, Inc., dated February 1, 2018; Replacement...
Consulting Agreements
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
First Amendment to Employment Agreement dated as of July 24, 2019 by and between Gemphire and Steve Gullans
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Employment Agreement by and between the Registrant and Seth Reno
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2019
Separation and Release Agreement with Dr. Lee Golden dated as of September 21, 2018
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2018
Separation and Release Agreement with Jeffrey S. Mathiesen dated as of September 21, 2018
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2018
AMENDMENT TO THE GEMPHIRE THERAPEUTICS INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: April 9, 2018 APPROVED BY THE STOCKHOLDERS: May 22,...
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
2018
Employment Agreement
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2018
Separation and Release Agreement between Gemphire Therapeutics Inc. and Mina Sooch dated May 30, 2017
Separation Agreements
Gemphire Therapeutics Inc.
Biotechnology
MI
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Gemphire Therapeutics Inc.
Biotechnology
2016
GEMPHIRE THERAPEUTICS INC. 2015 EQUITY INCENTIVE PLAN APPROVED BY THE BOARD OF DIRECTORS: April 28, 2015 APPROVED BY THE STOCKHOLDERS: April 28, 2015
Bonus & Incentive Agreements
Gemphire Therapeutics Inc.
Biotechnology
DE
2016